These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9352601)

  • 1. Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases.
    Burkhardt H; Kalden JR
    Rheumatol Int; 1997; 17(3):85-90. PubMed ID: 9352601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of new immunosuppressive drugs.
    Morris RE
    Ther Drug Monit; 1995 Dec; 17(6):564-9. PubMed ID: 8588221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil in animal models of autoimmune disease.
    Zandman-Goddard G; Shoenfeld Y
    Lupus; 2005; 14 Suppl 1():s12-6. PubMed ID: 15803926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases.
    Kovarik JM; Burtin P
    Expert Opin Emerg Drugs; 2003 May; 8(1):47-62. PubMed ID: 14610911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive therapy].
    Purice S
    Stud Cercet Med Interna; 1973; 14(3):209-16. PubMed ID: 4574134
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical studies with 15-deoxyspergualin in various animal models for autoimmune diseases.
    Schorlemmer HU; Dickneite G
    Ann N Y Acad Sci; 1993 Jun; 685():155-74. PubMed ID: 8363220
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice.
    Schorlemmer HU; Bartlett RR; Seiler FR
    Agents Actions; 1991 Sep; 34(1-2):151-5. PubMed ID: 1793021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive therapy in autoimmune diseases].
    Schwarz-Eywill M
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):93-100. PubMed ID: 10355057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases.
    Carlson RP; Baeder WL; Caccese RG; Warner LM; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():86-113. PubMed ID: 8363289
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine, FK-506, rapamycin, and other immunomodulators.
    Yocum DE
    Rheum Dis Clin North Am; 1996 Feb; 22(1):133-54. PubMed ID: 8907069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive drugs. II. Clinical use of immunosuppression.
    Br Med J; 1970 Dec; 4(5737):730-1. PubMed ID: 4923475
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoregulatory drugs: mechanistic basis for use in organ transplantation.
    Suthanthiran M; Strom TB
    Pediatr Nephrol; 1997 Oct; 11(5):651-7. PubMed ID: 9323301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
    Herrmann ML; Schleyerbach R; Kirschbaum BJ
    Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy in management of non-malignant disease.
    Fennelly JJ; Fitzgerald MX; Fitzgerald O
    J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressants: cellular and molecular mechanisms of action.
    Suthanthiran M; Morris RE; Strom TB
    Am J Kidney Dis; 1996 Aug; 28(2):159-72. PubMed ID: 8768909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive agents].
    Lagrue G; Bariéty J; Druet P
    Acquis Med Recent; 1970; ():43-61. PubMed ID: 5526182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.